GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients - (:unkn) unknown (ELSEVIER SCIENCE INC, 2021)
Keywords: ROS1(+); ALK(+); lorlatinib